LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
45 hedge funds and large institutions have $35M invested in Landos Biopharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less capital invested
Capital invested by funds: $120M → $35M (-$84.7M)
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$250K | |
| 2 | +$235K | |
| 3 | +$234K | |
| 4 |
Millennium Management
New York
|
+$90K |
| 5 |
BlackRock
New York
|
+$73.5K |
Top Sellers
| 1 | -$6.6M | |
| 2 | -$222K | |
| 3 | -$215K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$73K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$18K |